"","pert","cell","type","trend","WTCS","WTCS_Pval","WTCS_FDR","NCS","Tau","TauRefSize","NCSct","N_upset","N_downset","t_gn_sym","MOAss","PCIDss","MOA","Target","Disease.Area","Indication","Phase"
"1","thiotepa","HA1E","trt_cp","down",-0.422143900701905,2.51536756853038e-05,0.00121558283366225,-1.55609186854871,-99.5091477019188,2241,0,103,100,"CYP2B6","Cytochrome P450 inhibitor","5453","cytochrome P450 inhibitor","CYP2B6, CYP3A4","oncology","breast cancer, ovarian cancer, bladder cancer","Launched"
"2","phenoxybenzamine","HA1E","trt_cp","down",-0.395599835243155,2.62851559064421e-05,0.00121558283366225,-1.45824607627288,-98.3043284248104,2241,0,103,100,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ADRB2; CALM1; CALM2; CALM3","Adrenergic receptor antagonist","5284441","adrenergic receptor antagonist","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C","cardiology, endocrinology","hypertension, pheochromocytoma","Launched"
"3","IB-MECA","HA1E","trt_cp","down",-0.381407146128438,2.69379329570988e-05,0.00121558283366225,-1.40592948923342,-97.1441320838911,2241,0,103,100,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor agonist","3668","adenosine receptor agonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Phase 3"
"4","bendroflumethiazide","HA1E","trt_cp","down",-0.381053180555241,2.69379329570988e-05,0.00121558283366225,-1.40462471389666,-98.3043284248104,2241,0,103,100,"CA1; CA4; KCNMA1; SLC12A1; SLC12A3","Sodium/potassium/chloride transporter inhibitor","2315","sodium/potassium/chloride transporter inhibitor","SLC12A1, SLC12A3","cardiology","hypertension","Launched"
"5","AM-251","HA1E","trt_cp","down",-0.380197915273884,2.69814514271425e-05,0.00121558283366225,-1.40147206536245,-96.8763944667559,2241,0,103,100,"CNR1; GPR18; GPR55","Cannabinoid receptor antagonist","2125","cannabinoid receptor antagonist","CNR1, GPR18, GPR55","","","Preclinical"
"6","NSC-23766","HA1E","trt_cp","down",-0.376182140264194,2.71555253073176e-05,0.00121558283366225,-1.38666925800669,-98.1704596162427,2241,0,103,100,NA,"Ras GTPase inhibitor","409805","Ras GTPase inhibitor","","","","Preclinical"
"7","MD-920","HA1E","trt_cp","down",-0.376117443771576,2.71555253073176e-05,0.00121558283366225,-1.38643077609112,-95.3592146363231,2241,-0.0205227590732592,103,100,NA,NA,"6466","NFkB pathway inhibitor","AADACL2","","","Phase 1"
"8","KB-R7943","HA1E","trt_cp","down",-0.375398073737571,2.71990437773614e-05,0.00121558283366225,-1.38377905979596,-92.235609103079,2241,0,103,100,"SLC8A1; TRPC3; TRPC5; TRPC6","Sodium/calcium exchange inhibitor","4534086","sodium/calcium exchange inhibitor","SLC8A1, TRPC3, TRPC5, TRPC6","","","Preclinical"
"9","tetrahydrozoline","HA1E","trt_cp","down",-0.375087684665631,2.71990437773614e-05,0.00121558283366225,-1.38263491461199,-95.0914770191879,2241,-0.0161707916270918,103,100,NA,NA,"5419","adrenergic receptor agonist","","ophthalmology","eye irritation","Launched"
"10","dihydrexidine","HA1E","trt_cp","down",-0.37063758764252,2.73731176575365e-05,0.00121558283366225,-1.36623112486067,-98.4828201695671,2241,-0.879063201992402,103,100,"DRD1; DRD3; DRD4","Dopamine receptor agonist","5311070","dopamine receptor agonist","DRD1, DRD2, DRD3, DRD4, DRD5","","","Phase 2"
"11","carteolol","HA1E","trt_cp","down",-0.367038123295141,2.75471915377116e-05,0.00121558283366225,-1.35296290709707,-94.020526550647,2241,0,103,100,"ADRB1; ADRB2","Adrenergic receptor antagonist","2583","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","ophthalmology","intraocular pressure, glaucoma, ocular hypertension","Launched"
"12","bicalutamide","HA1E","trt_cp","down",-0.36666630947765,2.75471915377116e-05,0.00121558283366225,-1.35159234019548,-93.797411869701,2241,-0.959178538870209,103,100,"AR; CYP46A1; KLK3","Androgen receptor antagonist","2375","androgen receptor antagonist","AR","oncology","prostate cancer","Launched"
"13","aminoglutethimide","HA1E","trt_cp","down",-0.365627287462352,2.75907100077554e-05,0.00121558283366225,-1.34776233410855,-96.6532797858099,2241,-0.0226518011590551,103,100,"CYP11A1; CYP19A1; NR3C1","Glucocorticoid receptor antagonist","2145","glucocorticoid receptor antagonist","CYP11A1, CYP19A1","endocrinology, oncology","Cushing's syndrome, breast cancer","Launched"
"14","etilefrine","HA1E","trt_cp","down",-0.363602126123271,2.77212654178868e-05,0.00121558283366225,-1.34029725623581,-95.5823293172691,2241,0,103,100,"ADRA1A; ADRB1","Adrenergic receptor agonist","3306","adrenergic receptor agonist","ADRA1A, ADRB1","neurology/psychiatry, otolaryngology, endocrinology, pulmonary","headache, nasal congestion, fever, cough suppressant, common cold","Launched"
"15","pizotifen","HA1E","trt_cp","down",-0.362714837012837,2.77647838879305e-05,0.00121558283366225,-1.3370265625991,-90.3168228469433,2241,0,103,100,"ADRA1B; ADRA1D; ADRA2B; ADRA2C; HTR1B; HTR1D; HTR2B","Serotonin receptor antagonist","27400","serotonin receptor antagonist","HTR1A, HTR2A, HTR2C","neurology/psychiatry","migraine headache","Launched"
"16","ZM-241385","HA1E","trt_cp","down",-0.361298122012263,2.78518208280181e-05,0.00121558283366225,-1.33180431803089,-93.4850513163766,2241,-0.71095582889663,103,100,"ADORA1; ADORA2A; ADORA2B; ADORA3","Adenosine receptor antagonist","176407","adenosine receptor antagonist","ADORA1, ADORA2A, ADORA2B, ADORA3","","","Preclinical"
"17","BRL-37344","HA1E","trt_cp","down",-0.354700924964311,2.83087647634778e-05,0.00121558283366225,-1.30748596434993,-94.5113788487282,2241,-0.0269097016393464,103,100,"ADRB1; ADRB2; ADRB3","Adrenergic receptor agonist","9841972","adrenergic receptor agonist","ADRB1, ADRB2, ADRB3","","","Phase 2"
"18","raloxifene","HA1E","trt_cp","down",-0.351882438678125,2.8656912523828e-05,0.00121558283366225,-1.29709656020537,-95.7608210620259,2241,0,103,100,"ACVRL1; AOX1; BGLAP; EBP; ENG; ESR1; ESR2; PTGR1; RAC1; SERPINB9; SHBG; TFF1","Estrogen receptor antagonist; Selective estrogen receptor modulator (SERM)","5035","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","ESR1, ESR2","orthopedics, oncology","osteoporosis, breast cancer","Launched"
"19","pifithrin-mu","HA1E","trt_cp","down",-0.350706157845716,2.88745048740469e-05,0.00121558283366225,-1.29276059553693,-87.7286925479697,2241,0,103,100,"HSPA1A; TP53","HSP inhibitor","327653","HSP inhibitor","HSPA1A, TP53","","","Preclinical"
"20","sulfafurazole","HA1E","trt_cp","down",-0.348884614328421,2.9440244984616e-05,0.00121558283366225,-1.28604608645423,-83.4448906738063,2241,0,103,100,NA,"Bacterial antifolate","5344","bacterial antifolate","","infectious disease","urinary tract infections","Launched"
"21","calcipotriol","HA1E","trt_cp","down",-0.337693974575577,3.52499607354604e-05,0.00123471585027349,-1.24479554725586,-88.4426595269969,2241,0,103,100,"BGLAP; GC; VDR","Vitamin D receptor agonist","5353464","vitamin D receptor agonist","VDR","dermatology","psoriasis","Launched"
"22","E-4031","HA1E","trt_cp","down",-0.335214714000642,3.9057826864291e-05,0.00126226546510222,-1.23565658489194,-94.1990182954038,2241,0,103,100,"KCNH1; KCNH2","Potassium channel blocker","3185","potassium channel blocker","KCNH1, KCNH2","","","Phase 1"
"23","UCL-2077","HA1E","trt_cp","down",-0.334737267660808,3.9057826864291e-05,0.00126226546510222,-1.23389663913447,-88.2195448460509,2241,-0.0275457640736647,103,100,NA,"Slow after hyperpolarization channel blocker","24868317","slow afterhyperpolarization channel blocker","","","","Preclinical"
"24","RU-28318","HA1E","trt_cp","down",-0.332496528530385,4.37795808640409e-05,0.00130306633302323,-1.22563690605626,-94.1097724230254,2241,-0.0174377022790641,103,100,"NR3C2","Cytochrome P450 inhibitor","3034004","cytochrome P450 inhibitor","NR3C2","","","Phase 2"
"25","PETCM","HA1E","trt_cp","down",-0.331963898561365,4.37795808640409e-05,0.00130306633302323,-1.22367354436287,-90.8969210174029,2241,0,103,100,"CASP3","Caspase activator","224859","caspase activator","CASP3","","","Preclinical"
"26","TPCA-1","HA1E","trt_cp","down",-0.331231155708364,4.57814304860547e-05,0.00133837876553253,-1.22097253365682,-85.1851851851852,2241,0,103,100,"CDC42BPB; EPHB1; IKBKB; MAP3K9; NTRK3; NUAK1; RET; TNK2; TYK2","IKK inhibitor","9903786","IKK inhibitor","IKBKB","","","Preclinical"
"27","tamoxifen","HA1E","trt_cp","down",-0.327053407022468,5.60082709463426e-05,0.00150345566566012,-1.20557266468286,-82.6863007585899,2241,0,103,100,"ABCB1; ABCG2; AR; BGLAP; CCND1; CTSD; CYP2C9; CYP3A5; EBP; EBPL; ERBB2; ESR1; ESR2; ESRRG; FMO1; FMO2; FMO3; FMO4; FMO5; GPER1; IGFBP5; KCNH2; NCOR1; NCOR2; NR1I2; ODC1; PRKCA; PRKCB; PRKCE; PRKCG; PRKCI; PRKCZ; SHBG; TGFA; UGT1A4","Estrogen receptor antagonist; Selective estrogen receptor modulator (SERM)","2733526","estrogen receptor antagonist, selective estrogen receptor modulator (SERM)","EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ","oncology","breast cancer","Launched"
"28","R-96544","HA1E","trt_cp","down",-0.326690122183544,5.60082709463426e-05,0.00150345566566012,-1.20423353699944,-83.7126282909415,2241,0,103,100,NA,"Serotonin receptor antagonist","10668211","serotonin receptor antagonist","HTR2A","","","Preclinical"
"29","DR-2313","HA1E","trt_cp","down",-0.322536307950797,7.19577902173874e-05,0.00175992134498683,-1.18892189435746,-90.6738063364569,2241,0.0323535337878655,103,100,"PARP1; PARP3","PARP inhibitor","135522417","PARP inhibitor","PARP1, PARP3","","","Preclinical"
"30","U-18666A","HA1E","trt_cp","down",-0.318739903719757,9.60452633866187e-05,0.0021657782748751,-1.1749277237824,-70.8612226684516,2241,0.0285315807378146,103,100,NA,"Oxidosqualene cyclase inhibitor","415541","oxidosqualene cyclase inhibitor","","","","Preclinical"
"31","L-693403","HA1E","trt_cp","down",-0.31651473836439,0.00011184246801251,0.00240854379568084,-1.16672539820123,-83.3556448014279,2241,0,103,100,"SIGMAR1","Sigma receptor agonist; Sigma receptor antagonist","4687238","sigma receptor agonist, sigma receptor antagonist","DRD2, SIGMAR1","","","Preclinical"
"32","mepacrine","HA1E","trt_cp","down",-0.315906955645212,0.000121808197652535,0.00256780620702748,-1.16448501110672,-85.363676929942,2241,0,103,100,"AKT1; MTOR; NFKB1; PLA2G1B; PLA2G2A; PLA2G2D; PLA2G4A; PLA2G6; PLCL1; TP53","Cytokine production inhibitor; NFkB pathway inhibitor; TP53 activator","237","cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator","PLA2G1B","infectious disease","giardiasis","Launched"
"33","SKI-II","HA1E","trt_cp","down",-0.315763278778426,0.000121808197652535,0.00256780620702748,-1.16395539453822,-76.929941990183,2241,0,103,100,"SPHK1",NA,"753704","sphingosine kinase inhibitor","SPHK1","","","Preclinical"
"34","rosuvastatin","HA1E","trt_cp","down",-0.315692650480182,0.000121808197652535,0.00256780620702748,-1.16369504701122,-74.4310575635877,2241,-0.0269257851062334,103,100,"APOB; CRP; HMGCR; SLCO1B1","HMGCR inhibitor","446157","HMGCR inhibitor","HMGCR","endocrinology, cardiology","hyperlipidemia, dyslipidemia, hypertriglyceridemia, hypercholesterolemia, atherosclerosis","Launched"
"35","ceramide","HA1E","trt_cp","down",-0.315545952864699,0.000121808197652535,0.00256780620702748,-1.16315429546604,-91.4770191878626,2241,0,103,100,NA,"Phosphoenolpyruvate carboxylase activator; Serine/threonine protein phosphatase activator","NotFound","phosphoenolpyruvate carboxylase activator, serine/threonine protein phosphatase activator","","dermatology","cosmetic","Launched"
"36","fipronil","HA1E","trt_cp","down",-0.315013819128516,0.000131708649587495,0.00273264230268303,-1.16119276296853,-91.9678714859438,2241,0,103,100,"GABRB3","Chloride channel blocker; GABA gated chloride channel blocker","3352","chloride channel blocker, GABA gated chloride channel blocker","","infectious disease","flea control","Launched"
"37","nadolol","HA1E","trt_cp","down",-0.314259065147005,0.000142914655623768,0.00289584916836238,-1.15841061562154,-86.03302097278,2241,-1.05213696202576,103,100,"ADRB1; ADRB2; ADRB3","Adrenergic receptor antagonist","39147","adrenergic receptor antagonist","ADRB1, ADRB2, ADRB3","cardiology","angina pectoris, hypertension","Launched"
"38","warfarin","HA1E","trt_cp","down",-0.312536052937662,0.000155447974996376,0.00308986467946949,-1.15205930915019,-92.235609103079,2241,0,103,100,"ARSE; CYP2C8; CYP2C9; CYP4F2; F3; F7; NR1I2; PROS1; RP11-196G11.1; VKORC1; VKORC1L1","Vitamin K antagonist","54678486","vitamin K antagonist","VKORC1","hematology, cardiology","deep vein thrombosis (DVT), pulmonary embolism (PE), atrial fibrillation (AF), myocardial infarction","Launched"
"39","CITCO","HA1E","trt_cp","down",-0.310072661897142,0.000200206721436402,0.00377232476028343,-1.14297884450097,-82.8647925033467,2241,0,103,100,"NR1I3","CAR agonist","9600409","constitutive androstane receptor (CAR) agonist","NR1I3","","","Preclinical"
"40","moexipril","HA1E","trt_cp","down",-0.309185299142458,0.000219746514486058,0.00406058336136763,-1.13970787939945,-73.4939759036145,2241,-0.976217570554654,103,100,"ACE; ACE2","ACE inhibitor","91270","angiotensin converting enzyme inhibitor","ACE, ACE2","cardiology","hypertension","Launched"
"41","PD-123319","HA1E","trt_cp","down",-0.309026057694825,0.000219746514486058,0.00406058336136763,-1.13912088922528,-89.1120035698349,2241,0,103,100,"AGTR2","Angiotensin receptor antagonist","4701","angiotensin antagonist","AGTR2","","","Phase 1"
"42","diloxanide","HA1E","trt_cp","down",-0.30828598342702,0.000240221954641656,0.00436177010964518,-1.1363928537181,-92.8157072735386,2241,0,103,100,NA,"Protein synthesis inhibitor","11367","protein synthesis inhibitor","","infectious disease","amebiasis","Launched"
"43","N20C","HA1E","trt_cp","down",-0.307817768667664,0.000240221954641656,0.00436177010964518,-1.13466693708503,-71.4859437751004,2241,-0.706585397423448,103,100,NA,NA,"6603827","glutamate receptor antagonist","","","","Preclinical"
"44","melperone","HA1E","trt_cp","down",-0.306287296494238,0.000288462178685184,0.00507719949584693,-1.12902536486251,-78.0008924587238,2241,0,103,100,NA,"Dopamine receptor antagonist; Serotonin receptor antagonist","15387","dopamine receptor antagonist, serotonin receptor antagonist","DRD2, HTR2A","neurology/psychiatry","psychosis","Launched"
"45","DMeOB","HA1E","trt_cp","down",-0.305699893965931,0.000288462178685184,0.00507719949584693,-1.12686010250447,-72.289156626506,2241,0,103,100,NA,NA,"6891506","glutamate receptor modulator","GRM5","","","Preclinical"
"46","luzindole","HA1E","trt_cp","down",-0.303787718075969,0.000347690816414767,0.0059004723630565,-1.1198115075854,-86.5684962070504,2241,0,103,100,"MTNR1A; MTNR1B","Melatonin receptor antagonist","122162","melatonin receptor antagonist","MTNR1A, MTNR1B","","","Preclinical"
"47","atorvastatin","HA1E","trt_cp","down",-0.303555590784672,0.000347690816414767,0.0059004723630565,-1.1189558482004,-73.0923694779116,2241,-0.673478242765905,103,100,"AHR; APOA1; APOB; APOE; CCL2; CD40LG; CETP; CRP; CYP3A5; DPP4; FASLG; HMGCR; IL6; LDLR; LPL; MTTP; PON1; RHOA; SERPINE1; SLCO1B1; VCAM1","HMGCR inhibitor","2250","HMGCR inhibitor","AHR, DPP4, HMGCR","neurology/psychiatry, cardiology","stroke, heart attack","Launched"
"48","ZD-7114","HA1E","trt_cp","down",-0.301013997818307,0.000457096250104825,0.00732693242756098,-1.10958711838684,-81.2583668005355,2241,0.020246481174317,103,100,"ADRB3","Adrenergic receptor agonist","121877","adrenergic receptor agonist","ADRB3","","","Phase 1"
"49","SC-560","HA1E","trt_cp","down",-0.300512026418545,0.000457096250104825,0.00732693242756098,-1.10773676922364,-73.9402052655065,2241,0,103,100,NA,"Cyclooxygenase inhibitor","4306515","cyclooxygenase inhibitor","PTGS1","","","Preclinical"
"50","tetrabenazine","HA1E","trt_cp","down",-0.300245493121925,0.000502137866600136,0.00791095227887413,-1.10675428364259,-83.2217759928603,2241,0,103,100,"SLC18A1; SLC18A2","Vesicular monoamine transporter inhibitor","6018","vesicular monoamine transporter inhibitor","SLC18A1, SLC18A2","infectious disease, neurology/psychiatry","cholera, Huntington's disease","Launched"
"51","U-54494A","HA1E","trt_cp","down",-0.298340148160581,0.000602317384640913,0.00915649941401184,-1.09973086865022,-88.7103971441321,2241,0,103,100,NA,"Opioid receptor agonist","122015","opioid receptor agonist","OPRK1","","","Preclinical"
"52","MRS-1845","HA1E","trt_cp","down",-0.297310834425845,0.000660088153624029,0.00984583290748,-1.09593664888263,-84.7835787594824,2241,0,103,100,"ORAI1","Calcium channel blocker","5202074","calcium channel blocker","","","","Preclinical"
"53","PIT","HA1E","trt_cp","down",-0.297066355015313,0.000660088153624029,0.00984583290748,-1.09503545755398,-61.2672913877733,2241,0,103,100,"P2RY1","Purinergic receptor antagonist","124334","purinergic receptor antagonist","P2RY1","","","Preclinical"
"54","tyrphostin-AG-835","HA1E","trt_cp","down",-0.296603064211479,0.000660088153624029,0.00984583290748,-1.09332769143105,-65.7742079428826,2241,-0.0294218132093867,103,100,"EGFR","Protein tyrosine kinase inhibitor","5328769","protein tyrosine kinase inhibitor","EGFR","","","Preclinical"
"55","WAY-213613","HA1E","trt_cp","down",-0.296590360285117,0.000660088153624029,0.00984583290748,-1.09328086266845,-76.929941990183,2241,0,103,100,"SLC1A2","Glutamate inhibitor","24868316","glutamate inhibitor","SLC1A2","","","Preclinical"
"56","WAY-161503","HA1E","trt_cp","down",-0.295820527970681,0.000722254288081566,0.010530430857575,-1.09044313410563,-82.1954484605087,2241,-0.0168784156090349,103,100,NA,"Serotonin receptor agonist","3906894","serotonin receptor agonist","HTR2C","","","Preclinical"
"57","atovaquone","HA1E","trt_cp","down",-0.29564595010488,0.000722254288081566,0.010530430857575,-1.08979961137097,-83.2663989290495,2241,-0.0203386115068813,103,100,"DHODH","Mitochondrial electron transport inhibitor","44483269","mitochondrial electron transport inhibitor","","infectious disease","pneumonia","Launched"
"58","RS-79948","HA1E","trt_cp","down",-0.293750852226929,0.000864711999769874,0.0122010146335353,-1.08281396881382,-86.3900044622936,2241,-0.0130203796613565,103,100,NA,"Adrenergic receptor antagonist","9908992","adrenergic receptor antagonist","ADRA2A","","","Preclinical"
"59","PD-98059","HA1E","trt_cp","down",-0.292337341612374,0.00103167061009283,0.0139322522942774,-1.07760353613966,-77.9562695225346,2241,0,103,100,"AKT1; CHEK1; GSK3B; LCK; MAP2K1; MAP2K2; MAPK11; MAPK12; MAPK14; MAPK3; MAPK8; PRKCA; RAF1; ROCK1; RPS6KB1; SGK1","MAP kinase inhibitor; MEK inhibitor","4713","MEK inhibitor","AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1","","","Preclinical"
"60","indirubin","HA1E","trt_cp","down",-0.291810421402748,0.00103167061009283,0.0139322522942774,-1.07566122155875,-86.6131191432396,2241,0,103,100,"AHR; CCNE1; CDK1; CDK2; CDK4; CDK5; CDK5R1; CDK9; CYP1A1; GSK3A; GSK3B; LCK; LRRK1; LRRK2","CDK inhibitor; Glycogen synthase kinase inhibitor; Leucine rich repeat kinase inhibitor; Serum/glucocorticoid regulated kinase inhibitor; SRC inhibitor","10177","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK5, GSK3A","","","Phase 2/Phase 3"
"61","exemestane","HA1E","trt_cp","down",-0.290988824785393,0.00112815105817989,0.0149928600432952,-1.07263268125918,-80.4105310129407,2241,0,103,100,"CYP19A1","Aromatase inhibitor","60198","aromatase inhibitor","CYP19A1","oncology","breast cancer","Launched"
"62","clomipramine","HA1E","trt_cp","down",-0.29019905061322,0.00122939677873674,0.0160096793322826,-1.06972144372794,-74.2525658188309,2241,0,103,100,"HTR2B; SLC6A2; SLC6A3; SLC6A4","Serotonin transporter inhibitor (SERT)","2801","serotonin transporter (SERT) inhibitor","GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4","neurology/psychiatry","obsessive compulsive disorder (OCD)","Launched"
"63","SANT-1","HA1E","trt_cp","down",-0.286921970543741,0.00159862923782317,0.0198719516509066,-1.05764158745092,-69.4332887103971,2241,-0.0248059251692593,103,100,"DHH; IHH; PTCH1; SMO","Smoothened receptor antagonist","6878030","smoothened receptor antagonist","SHH, SMO","","","Preclinical"
"64","anabasine","HA1E","trt_cp","down",-0.286434353780899,0.00174604805509647,0.0212841868488099,-1.05584415184102,-77.599286033021,2241,0,103,100,NA,"Acetylcholine receptor agonist","2181","acetylcholine receptor agonist","","","","Preclinical"
"65","L-745870","HA1E","trt_cp","down",-0.284806356126353,0.00190314973195451,0.0228000910014863,-1.04984308465032,-80.9013833110219,2241,0,103,100,"DRD1; DRD3; DRD4; HTR6; HTR7","Dopamine receptor antagonist","5311200","dopamine receptor antagonist","DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7","","","Preclinical"
"66","naftifine","HA1E","trt_cp","down",-0.283578307466373,0.00207102223014839,0.0244040763099229,-1.04531629525268,-56.5818830879072,2241,0,103,100,"SQLE","Fungal squalene epoxidase inhibitor","47641","fungal squalene epoxidase inhibitor","","infectious disease","tinea pedis, tinea cruris, tinea corporis","Launched"
"67","RS-67506","HA1E","trt_cp","down",-0.282001552088323,0.00244839264313301,0.0279548651696449,-1.03950411552345,-77.1976796073182,2241,-0.0311851234657034,103,100,"HTR4","Serotonin receptor partial agonist","133076","serotonin receptor partial agonist","HTR4","","","Preclinical"
"68","NAN-190","HA1E","trt_cp","down",-0.281715322179988,0.00244839264313301,0.0279548651696449,-1.03844902499116,-67.2913877733155,2241,0,103,100,"ADRA1A; ADRA1B; ADRA1D; HTR1F","Serotonin receptor agonist","4431","serotonin receptor agonist","ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F","","","Preclinical"
"69","fulvestrant","HA1E","trt_cp","down",-0.279132869504389,0.00313813863409187,0.0342312601633815,-1.02892967956717,-83.5787594823739,2241,0,103,100,"CCND1; EPHX2; ESR1; ESR2; ESRRA; GPER1; RB1","Estrogen receptor antagonist","73707501","estrogen receptor antagonist","ESR1, ESR2, GPER1","oncology","breast cancer","Launched"
"70","BML-190","HA1E","trt_cp","down",-0.27797299098062,0.00340555963251089,0.0366438535405457,-1.02465417650686,-77.9562695225346,2241,0,103,100,"CNR2","Cannabinoid receptor inverse agonist","2415","cannabinoid receptor inverse agonist","CNR2","","","Preclinical"
"71","metergoline","HA1E","trt_cp","down",-0.27698920439667,0.00369260746091965,0.0390737896555431,-1.02102777730714,-69.9241410084784,2241,0.336007151428605,103,100,"HTR1B; HTR1D; HTR1E; HTR1F; HTR2B; HTR5A; HTR6; HTR7; SCN2A","Dopamine receptor agonist; Serotonin receptor antagonist","28693","dopamine receptor agonist, serotonin receptor antagonist","HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","neurology/psychiatry, endocrinology","seasonal affective disorder, anxiety, hyperprolactinemia","Launched"
"72","progesterone","HA1E","trt_cp","down",-0.276790508397513,0.00369260746091965,0.0390737896555431,-1.02029535116505,-69.5671575189647,2241,0,103,100,"AKR1C1; AKR1C2; AKR1D1; APOD; AR; CATSPER1; CATSPER2; CATSPER3; CATSPER4; CATSPERB; CATSPERD; CATSPERG; CGA; CYP11B1; CYP17A1; CYP21A2; ESR1; GNAI1; GNAS; GNGT1; HRAS; HSD3B1; HSD3B2; HVCN1; KCNU1; LHB; NR1I2; NR3C1; NR3C2; OPRK1; ORM1; PAQR5; PGR; SERPINA6; SHBG; SRD5A1; SRD5A3; TRPC5","Progesterone receptor agonist","5994","progesterone receptor agonist","CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5","obstetrics/gynecology, endocrinology","infertility, amenorrhea","Launched"
"73","vinpocetine","HA1E","trt_cp","down",-0.27665317776853,0.00369260746091965,0.0390737896555431,-1.01978912787316,-76.5283355644801,2241,0,103,100,"PDE1A; PDE1C; SCN10A","Phosphodiesterase inhibitor; Sodium channel blocker","5673","phosphodiesterase inhibitor, sodium channel blocker","PDE1A, PDE1C","neurology/psychiatry","stroke, senile dementia","Launched"
"74","mephenytoin","HA1E","trt_cp","down",-0.276433935410914,0.00400060943265449,0.0417087130415313,-1.01898096447352,-74.6541722445337,2241,0,103,100,"NR1I2; SCN5A","Hydantoin antiepileptic","4060","hydantoin antiepileptic","SCN5A","neurology/psychiatry","seizures","Launched"
"75","butein","HA1E","trt_cp","down",-0.276125004285676,0.00400060943265449,0.0417087130415313,-1.01784219352095,-63.6769299419902,2241,-0.0305352658056283,103,100,"ACE; CXCL8; IL6; SIRT1; SRD5A1; SRD5A2; TNF","EGFR inhibitor; SRC inhibitor","5281222","EGFR inhibitor, SRC inhibitor","ACE","","","Preclinical"
"76","chlortetracycline","HA1E","trt_cp","down",-0.275592479062196,0.00400060943265449,0.0417087130415313,-1.01587921793685,-74.2971887550201,2241,-0.0203175843587371,103,100,NA,"Protein synthesis inhibitor","73707519","protein synthesis inhibitor","","ophthalmology","conjunctivitis","Launched"
"77","ramipril","HA1E","trt_cp","down",-0.274971688467557,0.00432997897318083,0.0443477855340981,-1.01359088167336,-85.0513163766176,2241,0,103,100,"ACE; BDKRB1","ACE inhibitor","5362129","angiotensin converting enzyme inhibitor","ACE","cardiology","hypertension","Launched"
"78","mitotane","HA1E","trt_cp","down",-0.274969796082778,0.00432997897318083,0.0443477855340981,-1.01358390603173,-57.6082106202588,2241,0,103,100,"AR; CYP11A1; CYP11B1; CYP3A4; ESR1; FDX1; PGR","Antineoplastic","4211","antineoplastic agent","CYP11A1, CYP11B1, ESR1","oncology","adrenal cortical carcinoma","Launched"
"79","AMN-082","HA1E","trt_cp","down",-0.274645315477892,0.00432997897318083,0.0443477855340981,-1.01238781713899,-54.7077197679607,2241,0,103,100,"GRM7","Glutamate receptor modulator; Glutamate receptor positive allosteric modulator","1894361","glutamate receptor modulator","GRM7","","","Preclinical"
"80","GBR-12935","HA1E","trt_cp","down",-0.273846013024949,0.00468130358184425,0.0473550489560278,-1.00944145679725,-69.5225345827755,2241,0.730921055764262,103,100,"AGTR1; SLC6A3","Dopamine uptake inhibitor","3456","dopamine reuptake inhibitor","AGTR1, SLC6A3","","","Preclinical"
"81","JTE-013","HA1E","trt_cp","down",-0.273532068070038,0.00468130358184425,0.0473550489560278,-1.00828420404364,-76.3052208835341,2241,0,103,100,"P2RY10; S1PR2","Lysophospholipid receptor antagonist","10223146","lysophospholipid receptor antagonist","P2RY10, S1PR2","","","Preclinical"
"82","SC-9","HA1E","trt_cp","down",-0.271615540002477,0.00547216473794983,0.0536888989532926,-1.00121956628192,-50.9593931280678,2241,-0.0252466896070755,103,100,NA,"Protein tyrosine kinase activator","124172","protein tyrosine kinase activator","PRKCA","","","Preclinical"
"83","oxfendazole","HA1E","trt_cp","down",-0.271578826549498,0.00547216473794983,0.0536888989532926,-1.00108423445419,-70.0133868808568,2241,-0.0285699007787825,103,100,NA,"Anthelmintic","40854","anthelmintic agent","","infectious disease","lungworms, tapeworm, gastrointestinal roundworms","Launched"
"84","halcinonide","HA1E","trt_cp","down",-0.269043175267327,0.0068820108527231,0.0646107641977002,-0.991737406666084,-67.1128960285587,2241,0,103,100,"NR3C1; SMO","Glucocorticoid receptor agonist","73707616","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","Launched"
"85","piperine","HA1E","trt_cp","down",-0.268716120779008,0.0068820108527231,0.0646107641977002,-0.990531830015564,-73.1369924141008,2241,-0.0219355322254504,103,100,"MAOA; MAOB; NR1I2; TRPV1","Monoamine oxidase inhibitor","638024","monoamine oxidase inhibitor","MAOA, MAOB, TRPV1","","","Phase 1"
"86","ZD-2079","HA1E","trt_cp","down",-0.268685058642825,0.0068820108527231,0.0646107641977002,-0.990417329871291,-68.4515841142347,2241,-0.0238253766057261,103,100,"ADRB3","Adrenergic receptor agonist","158794","adrenergic receptor agonist","ADRB3","","","Phase 2"
"87","propoxycaine","HA1E","trt_cp","down",-0.268148451825282,0.007416722294151,0.0686906267130196,-0.988439308859977,-66.5327978580991,2241,0,103,100,NA,"Local anesthetic","6843","local anesthetic","","neurology/psychiatry","anesthetic","Launched"
"88","MR-16728","HA1E","trt_cp","down",-0.266334543202914,0.0085973783864387,0.0775772866929466,-0.98175294325606,-51.8072289156626,2241,0,103,100,NA,"Acetylcholine release enhancer; Acetylcholine release stimulant","378811","acetylcholine release enhancer","","","","Preclinical"
"89","ivermectin","HA1E","trt_cp","down",-0.266186561080126,0.0085973783864387,0.0775772866929466,-0.981207456805637,-59.6608656849621,2241,0.332248352879192,103,100,"CHRNA7; GABRB3; GLRA3; P2RX7","GABA receptor agonist","45114068","benzodiazepine receptor agonist","CHRNA7, P2RX7","infectious disease","gastrointestinal roundworms, lungworms, cattle grubs, mites, lice, horn flies","Launched"
"90","alfadolone-acetate","HA1E","trt_cp","down",-0.265421832478176,0.00925109108420132,0.0825040057957609,-0.978388541366702,-70.4149933065596,2241,-0.0254773118229127,103,100,NA,NA,"24733","benzodiazepine receptor agonist","","","","Phase 2"
"91","fluocinolone-acetonide","HA1E","trt_cp","down",-0.265398385107931,0.00925109108420132,0.0825040057957609,-0.97830211050245,-77.7331548415886,2241,-0.0162415996163365,103,100,NA,NA,"6215","glucocorticoid receptor agonist","NR3C1, SERPINA6","dermatology","seborrheic dermatitis","Launched"
"92","naringin","HA1E","trt_cp","down",-0.264468201337003,0.00993996670575931,0.0874762753599913,-0.974873300090193,-72.1106648817492,2241,-0.0129585156071726,103,100,"SLCO1A2","Cytochrome P450 inhibitor","442428","cytochrome P450 inhibitor","SLCO1A2","","","Preclinical"
"93","reserpine","HA1E","trt_cp","down",-0.26417493791535,0.00993996670575931,0.0874762753599913,-0.973792282870667,-64.8817492190986,2241,-0.813495826166967,103,100,"ABCG2; BIRC5; DBH; PNMT; SLC18A1; SLC18A2; TH","Vesicular monoamine transporter inhibitor","11908593","vesicular monoamine transporter inhibitor","SLC18A1, SLC18A2","cardiology","hypertension","Launched"
"94","indirubin-3-monoxime","HA1E","trt_cp","down",-0.261517002756227,0.0114617205662501,0.0981981413763221,-0.963994696594128,-66.7112896028559,2241,-0.0221783421237764,103,100,NA,NA,"3707","CDK inhibitor, glycogen synthase kinase inhibitor","CDK1, CDK2, CDK5, CDK5R1, GSK3B","","","Preclinical"
"95","dilazep","HA1E","trt_cp","down",-0.260980161306644,0.0122900293658284,0.103957406503959,-0.962015810690512,-61.4457831325301,2241,-0.641519922498232,103,100,"CACNA1C; SLC29A1","Adenosine reuptake inhibitor","3074","adenosine reuptake inhibitor","SLC29A1","cardiology","coronary heart disease","Launched"
"96","ibuprofen","HA1E","trt_cp","down",-0.260577636723946,0.0122900293658284,0.103957406503959,-0.960532038855872,-67.9161088799643,2241,-0.960716009813967,103,100,"ACSM2A; AKR1C2; AKR1C3; APP; ASIC1; BCL2; CFTR; CYP2C8; CYP2C9; FABP2; FABP4; GP1BA; LTF; PLAT; PPARA; PPARG; S100A7; SLC5A8; TF; THBD","Cyclooxygenase inhibitor; NFkB pathway inhibitor","3672","cyclooxygenase inhibitor","","neurology/psychiatry, rheumatology, otolaryngology, obstetrics/gynecology, endocrinology, dental","headache, muscle pain, rheumatoid arthritis, backache, common cold, menstrual pain, fever, toothache","Launched"
"97","phenazopyridine","HA1E","trt_cp","down",-0.260540327169402,0.0122900293658284,0.103957406503959,-0.960394509699703,-61.0441767068273,2241,-0.966811050761729,103,100,"SCN1A","Local anesthetic","8691","local anesthetic","SCN1A","infectious disease","urinary tract infections","Launched"
"98","SR-57227A","HA1E","trt_cp","down",-0.259998946091298,0.0131762177305649,0.110075670246471,-0.958398889978508,-49.9776885319054,2241,0,103,100,"HTR3A","Serotonin receptor agonist","131746","serotonin receptor agonist","HTR3A","","","Phase 2"
"99","GR-135531","HA1E","trt_cp","down",-0.259869014706932,0.0131762177305649,0.110075670246471,-0.957919941519594,-79.830432842481,2241,-0.0191583988303919,103,100,NA,"Melatonin receptor agonist","4284525","melatonin receptor agonist","","","","Preclinical"
"100","betamethasone-acetate","HA1E","trt_cp","down",-0.259849703762491,0.0131762177305649,0.110075670246471,-0.957848758201372,-64.1677822400714,2241,0,103,100,NA,NA,"443967","glucocorticoid receptor agonist","NR3C1","dermatology","corticosteroid-responsive dermatoses","Launched"
"101","meclizine","HA1E","trt_cp","down",-0.258321413545944,0.0150961655919563,0.122919806155908,-0.952215229030875,-64.524765729585,2241,0,103,100,"NR1I3",NA,"92303","constitutive androstane receptor (CAR) agonist","NR1I3","gastroenterology, neurology/psychiatry","nausea, vomiting, motion sickness","Launched"
"102","nafadotride","HA1E","trt_cp","down",-0.258064259642914,0.0150961655919563,0.122919806155908,-0.951267317437684,-79.607318161535,2241,-0.0265991247592784,103,100,"DRD3","Dopamine receptor antagonist","3408722","dopamine receptor antagonist","DRD2, DRD3, HTR1A","","","Preclinical"
"103","cilastatin","HA1E","trt_cp","down",-0.257384063988323,0.0161436769251451,0.129589312973269,-0.948760004349963,-63.0968317715306,2241,0,103,100,"DPEP1","Dehydropeptidase inhibitor","6435415","dehydropeptidase inhibitor","DPEP1","","","Launched"
"104","ephedrine-(racemic)","HA1E","trt_cp","down",-0.257158065614818,0.0161436769251451,0.129589312973269,-0.947926937164266,-70.8165997322624,2241,0,103,100,NA,NA,"NotFound","adrenergic receptor agonist","ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, FOS, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF","cardiology, pulmonary, neurology/psychiatry, endocrinology","hypotension, asthma, narcolepsy, obesity","Launched"
"105","FR-122047","HA1E","trt_cp","down",-0.256543548396625,0.0161436769251451,0.129589312973269,-0.945661725598442,-64.078536367693,2241,-0.0283698517679531,103,100,NA,"Cyclooxygenase inhibitor","196841","cyclooxygenase inhibitor","","","","Preclinical"
"106","BW-723C86","HA1E","trt_cp","down",-0.255882330479733,0.0172592511454823,0.137012635281013,-0.943224367574073,-53.1012940651495,2241,0,103,100,"HTR2B","Serotonin receptor agonist","5311036","serotonin receptor agonist","HTR2A, HTR2B, HTR2C","","","Preclinical"
"107","L-168049","HA1E","trt_cp","down",-0.252861070131656,0.0210093900237998,0.161025271503293,-0.932087504877265,-66.309683177153,2241,-0.653681049869303,103,100,"GCGR","Glucagon receptor antagonist","5311276","glucagon receptor antagonist","GCGR","","","Preclinical"
"108","amlodipine","HA1E","trt_cp","down",-0.252570603075089,0.0210093900237998,0.161025271503293,-0.9310167955195,-57.4743418116912,2241,0,103,100,"ABCG2; CA1; CACNA1B; CACNA1C; CACNA1D; CACNA1S; CACNA2D1; CACNA2D3; CACNB1; CACNB2; CYP2B6; SMPD1","Calcium channel blocker","2162","calcium channel blocker","CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1","cardiology","hypertension, chronic stable angina, vasospastic angina, coronary artery disease (CAD)","Launched"
"109","flunisolide","HA1E","trt_cp","down",-0.252276758842806,0.0223870759892107,0.169968687288975,-0.929933637336435,-43.685854529228,2241,0,103,100,"NR3C1","Cytochrome P450 inhibitor","5702174","cytochrome P450 inhibitor","NR3C1","allergy","allergic rhinitis","Launched"
"110","azaperone","HA1E","trt_cp","down",-0.251876210889404,0.0223870759892107,0.169968687288975,-0.928457151682572,-53.2797858099063,2241,0,103,100,"DRD3","Dopamine receptor antagonist","15443","dopamine receptor antagonist","DRD2, DRD3","neurology/psychiatry","sedative","Launched"
"111","CO-102862","HA1E","trt_cp","down",-0.25121295457687,0.0238390479829864,0.179333326093652,-0.926012279796512,-64.4355198572066,2241,0,103,100,"SCN2A; SCN4A; SCN9A","Sodium channel blocker","10221150","sodium channel blocker","SCN4A, SCN9A","","","Phase 1"
"112","flumazenil","HA1E","trt_cp","down",-0.250955179166878,0.0238390479829864,0.179333326093652,-0.925062077226407,-45.1584114234717,2241,-0.023723441296722,103,100,"GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRB1; GABRB2; GABRB3; GABRD; GABRE; GABRG1; GABRG2; GABRG3; GABRP; GABRQ","Benzodiazepine receptor antagonist","3373","benzodiazepine receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ","neurology/psychiatry","sedative","Launched"
"113","PAC-1","HA1E","trt_cp","down",-0.24905900915224,0.0269838449429949,0.198665424255091,-0.918072482597045,-54.8862115127175,2241,0.538777970402613,103,100,"CASP3","Caspase activator","135421197","caspase activator","CASP3","","","Phase 1"
"114","6-benzylaminopurine","HA1E","trt_cp","down",-0.245884136081214,0.0323253672338734,0.230388426892042,-0.906369378131288,-56.9388665774208,2241,-0.912808217680498,103,100,NA,"Purinergic receptor activator","62389","purinergic receptor activator","","","","Preclinical"
"115","methoxsalen","HA1E","trt_cp","down",-0.24555756029654,0.0323253672338734,0.230388426892042,-0.905165566061156,-66.9790272199911,2241,-0.0181033113212231,103,100,"ACHE; CYP1A2","DNA synthesis inhibitor","4114","DNA synthesis inhibitor","CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4","dermatology","psoriasis","Launched"
"116","BMS-191011","HA1E","trt_cp","down",-0.24555197868764,0.0323253672338734,0.230388426892042,-0.905144991332474,-68.8531905399375,2241,-0.334903646793015,103,100,"KCNMA1","Potassium channel activator","10474339","potassium channel activator","KCNMA1","","","Preclinical"
"117","ABT-737","HA1E","trt_cp","down",-0.245501927487645,0.0323253672338734,0.230388426892042,-0.904960494374935,-52.0303435966087,2241,0,103,100,"BAD; BCL2; BCL2L1; BCL2L2","BCL inhibitor","11228183","BCL inhibitor","BCL2, BCL2L1, BCL2L2","","","Phase 1/Phase 2"
"118","nalbuphine","HA1E","trt_cp","down",-0.245433433422713,0.0342699465493095,0.241661755964411,-0.90470801398304,-62.2489959839357,2241,0,103,100,"OPRD1; OPRK1; OPRM1","Opioid receptor agonist; Opioid receptor antagonist","23581814","opioid receptor agonist, opioid receptor antagonist","OPRD1, OPRK1, OPRM1","neurology/psychiatry","pain relief","Launched"
"119","BI-2536","HA1E","trt_cp","down",-0.243418928579497,0.0384308997848403,0.266023562360615,-0.897282217707248,-52.6996876394467,2241,0.025729553249814,103,100,"BRD4; PLK1; PLK2; PLK3","PLK inhibitor","11364421","PLK inhibitor","BRD4, PLK1, PLK2, PLK3","","","Phase 2"
"120","tyrphostin-AG-18","HA1E","trt_cp","down",-0.239983975002547,0.0454072586806183,0.305033764058836,-0.884620413708549,-44.1767068273092,2241,0,103,100,"EGFR","EGFR inhibitor; Tyrosine kinase inhibitor","NotFound","EGFR inhibitor, tyrosine kinase inhibitor","EGFR","","","Preclinical"
"121","lasalocid","HA1E","trt_cp","down",-0.239624935038368,0.0454072586806183,0.305033764058836,-0.8832969333318,-55.86791610888,2241,0,103,100,NA,"Bacterial permeability inducer","5360807","bacterial permeability inducer","","infectious disease","coccidiosis","Launched"
"122","etifenin","HA1E","trt_cp","down",-0.239564160384278,0.0454072586806183,0.305033764058836,-0.883072907958257,-42.793395805444,2241,-0.021740750205625,103,100,NA,"Compound used in hepatobiliary scans of the liver","170344","renal function diagnostic agent","","","","Preclinical"
"123","altanserin","HA1E","trt_cp","down",-0.236852422045562,0.0532625383566355,0.314451408995329,-0.873076994310112,-47.3003123605533,2241,-0.88263403535445,103,100,NA,"Serotonin receptor antagonist","3033677","serotonin receptor antagonist","HTR2A","","","Phase 2"
"124","SB-216763","HA1E","trt_cp","down",-0.236733629300496,0.0532625383566355,0.314451408995329,-0.872639104708171,-45.3815261044177,2241,0,103,100,"CDK2; GSK3A; GSK3B","Glycogen synthase kinase inhibitor","176158","glycogen synthase kinase inhibitor","CCNA2, CDK2, GSK3A, GSK3B","","","Preclinical"
"125","GBR-13069","HA1E","trt_cp","down",-0.236118794354613,0.0560728741151226,0.314451408995329,-0.870372721945808,-44.9799196787149,2241,-0.821193203070493,103,100,"SLC6A3","Dopamine uptake inhibitor","5974189","dopamine reuptake inhibitor","SLC6A3","","","Preclinical"
"126","tetrindole","HA1E","trt_cp","down",-0.235975912152651,0.0560728741151226,0.314451408995329,-0.869846034642582,-44.4890673806336,2241,0,103,100,"MAOA","Monoamine oxidase inhibitor","160019","monoamine oxidase inhibitor","MAOA","","","Phase 3"
"127","diphenidol","HA1E","trt_cp","down",-0.235866502552533,0.0560728741151226,0.314451408995329,-0.869442732856626,-47.2556894243641,2241,0,103,100,"CHRM1; CHRM4","Acetylcholine receptor agonist","3055","acetylcholine receptor agonist","CHRM1, CHRM2, CHRM3, CHRM4","neurology/psychiatry","vertigo","Launched"
"128","NVP-AUY922","HA1E","trt_cp","down",-0.23566192216117,0.0560728741151226,0.314451408995329,-0.868688615876762,-49.5760821062026,2241,-0.548443714935272,103,100,"HSP90AA1; HSP90AA2; HSP90AB1; HSP90B1; TRAP1","HSP inhibitor","10096043","HSP inhibitor","HSP90AA1, HSP90AB1","","","Phase 2"
"129","Ro-10-5824","HA1E","trt_cp","down",-0.233983090899588,0.0620255045215908,0.314451408995329,-0.86250016764745,-36.9924141008478,2241,0,103,100,"DRD4",NA,"16759175","dopamine receptor agonist","DRD4","","","Preclinical"
"130","probucol","HA1E","trt_cp","down",-0.233875259056693,0.0620255045215908,0.314451408995329,-0.862102681734185,-36.9031682284694,2241,0,103,100,"ABCA1; ABCB11; APOA1; APOA2; APOB; APOE; CES1; CETP; SCARB1; SELE; VCAM1","Atherogenesis inhibitor","4912","atherogenesis inhibitor","ABCA1, ABCB11, CES1","cardiology","coronary artery disease (CAD)","Launched"
"131","naproxen","HA1E","trt_cp","down",-0.233776949264362,0.0620255045215908,0.314451408995329,-0.861740295665857,-57.206604194556,2241,-0.863041720181706,103,100,"AKR1C2; AKR1C3; CYP2C9; LTF; PNLIP; TF","Cyclooxygenase inhibitor","1302","cyclooxygenase inhibitor","PTGS1, PTGS2","neurology/psychiatry, rheumatology, dental, otolaryngology, endocrinology","pain relief, rheumatoid arthritis, headache, toothache, backache, muscle pain, common cold, fever","Launched"
"132","clemastine","HA1E","trt_cp","down",-0.233320989991812,0.0651635561187426,0.314451408995329,-0.860059554773414,-50.780901383311,2241,0,103,100,"HRH1","Histamine receptor antagonist","26987","histamine receptor antagonist","HRH1","allergy","allergic rhinitis, urticaria","Launched"
"133","flavoxate","HA1E","trt_cp","down",-0.232766624061518,0.0651635561187426,0.314451408995329,-0.858016070750796,-39.9821508255243,2241,-0.0257404821225237,103,100,"CHRM1","Acetylcholine receptor antagonist","3354","acetylcholine receptor antagonist","CHRM1, CHRM2","urology","urinary incontinence, interstitial cystitis (IC), urethritis, prostatitis","Launched"
"134","GW-311616","HA1E","trt_cp","down",-0.231778350885344,0.0684082279675016,0.314451408995329,-0.854373133234009,-40.9638554216867,2241,-0.0238986437967369,103,100,"ELANE","Leukocyte elastase inhibitor","44483335","elastase inhibitor, leukocyte elastase inhibitor","ELANE","","","Phase 1"
"135","mebeverine","HA1E","trt_cp","down",-0.231597303090266,0.0684082279675016,0.314451408995329,-0.853705761275608,-48.549754573851,2241,0,103,100,"CHRM1; CHRM4; IL13","Acetylcholine receptor antagonist","4031","acetylcholine receptor antagonist","CHRM1","gastroenterology","irritable bowel syndrome","Launched"
"136","BMY-7378","HA1E","trt_cp","down",-0.23090317792288,0.0717489885981173,0.314451408995329,-0.851147101712057,-46.3186077643909,2241,-0.0255344130513615,103,100,"ADRA1A; ADRA1B; ADRA1D","Adrenergic receptor antagonist; Serotonin receptor antagonist","2419","adrenergic receptor antagonist, serotonin receptor antagonist","ADRA1A, ADRA1B, ADRA1D, HTR1A","","","Preclinical"
"137","caffeic-acid","HA1E","trt_cp","down",-0.229820036824188,0.0751865778245804,0.314451408995329,-0.847154465425325,-34.8505131637662,2241,0,103,100,"ALOX5; MIF; RELA; TNF","HIV integrase inhibitor; Lipoxygenase inhibitor; NFkB pathway inhibitor; Nitric oxide production inhibitor; PPAR receptor modulator; TNF production inhibitor; Tumor necrosis factor production inhibitor","689043","HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor","ALOX5, MIF","","","Preclinical"
"138","phensuximide","HA1E","trt_cp","down",-0.229275456927406,0.0787549835719951,0.314451408995329,-0.845147054332215,-51.7179830432842,2241,0.0188448960169953,103,100,NA,"Succinimide antiepileptic","6839","succinimide antiepileptic","","neurology/psychiatry","seizures","Launched"
"139","RS-102895","HA1E","trt_cp","down",-0.224826687050513,0.0939448009114856,0.314451408995329,-0.828748156660195,-48.549754573851,2241,-0.0165749631332039,103,100,"CCR2","CCR antagonist","10000456","CCR antagonist","CCR2","","","Preclinical"
"140","SDZ-21009","HA1E","trt_cp","down",-0.224374776740118,0.0979692802249592,0.314451408995329,-0.827082340908387,-50.2008032128514,2241,0,103,100,NA,NA,"193949","adrenergic receptor antagonist, serotonin receptor antagonist","HTR1A, HTR1B","","","Preclinical"
"141","PK-11195","HA1E","trt_cp","down",-0.222770330645718,0.102095114055165,0.314451408995329,-0.82116808864306,-31.5930388219545,2241,-0.749723564854256,103,100,"NR1I2; NR1I3; TSPO","Benzodiazepine receptor antagonist","1345","benzodiazepine receptor antagonist","TSPO","","","Phase 1"
"142","diclofenamide","HA1E","trt_cp","down",-0.220741203279231,0.110622188353248,0.314451408995329,-0.813688391340813,-38.1972333779563,2241,0,103,100,"CA1; CA12; CA3; CA4; CA7","Carbonic anhydrase inhibitor","3038","carbonic anhydrase inhibitor","CA1, CA12, CA2, CA4, CA7","ophthalmology, neurology/psychiatry","glaucoma, epilepsy","Launched"
"143","CNQX","HA1E","trt_cp","down",-0.219059066511617,0.119505026143938,0.314451408995329,-0.80748775847245,-59.1253904506917,2241,-0.0159188499270139,103,100,"GRIA1; GRIA3; GRIA4","Glutamate receptor antagonist","3721046","glutamate receptor antagonist","GRIA1, GRIA2, GRIA3, GRIA4","","","Phase 1"
"144","alisertib","HA1E","trt_cp","down",-0.218958195329164,0.119505026143938,0.314451408995329,-0.807115930698733,-45.6492637215529,2241,-0.556909992182126,103,100,"AURKA","Aurora kinase inhibitor","24771867","Aurora kinase inhibitor","AURKA","","","Phase 3"
"145","benzbromarone","HA1E","trt_cp","down",-0.217930537426673,0.124057253943633,0.314451408995329,-0.80332781460122,-42.2579205711736,2241,-0.0160665562920244,103,100,"ABCC1; CYP2C9; SLC22A12","Chloride channel blocker","2333","chloride channel blocker","ABCC1","rheumatology","gout","Launched"
"146","GW-6471","HA1E","trt_cp","down",-0.217045439461075,0.128673606208937,0.314451408995329,-0.800065197884868,-43.462739848282,2241,0,103,100,"PPARA","PPAR receptor antagonist","44634742","PPAR receptor antagonist","PPARA","","","Preclinical"
"147","sertraline","HA1E","trt_cp","down",-0.216561635260069,0.128673606208937,0.314451408995329,-0.798281816005128,-33.2887103971441,2241,0,103,100,"CYP2C9; PGRMC1; SIGMAR1; SLC6A3; SLC6A4","Serotonin receptor antagonist","6093397","selective serotonin reuptake inhibitor (SSRI)","SLC6A3, SLC6A4","neurology/psychiatry, obstetrics/gynecology","depression, obsessive compulsive disorder (OCD), panic disorders, posttraumatic stress disorder, premenstrual syndrome, social anxiety disorder","Launched"
"148","pregnenolone","HA1E","trt_cp","down",-0.215360958113614,0.138118354484833,0.314451408995329,-0.793855922509463,-40.9192324854975,2241,0,103,100,"BPNT1; CGA; CYP11A1; CYP17A1; CYP21A2; CYP7B1; HSD3B1; HSD3B2; LHB; NR1I2; PGR; POMC; STS; SULT2A1; SULT2B1","Acetylcholine release enhancer; Dopamine release enhancer; GABA receptor negative allosteric modulator; glutamate receptor modulator; Glutamate receptor modulator","7088398","glutamate receptor modulator","SULT2B1","rheumatology","rheumatoid arthritis","Launched"
"149","vorinostat","HA1E","trt_cp","down",-0.214466660481048,0.14291145701622,0.314451408995329,-0.790559394307149,-27.264614011602,2241,0,103,100,"HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8; HDAC9","HDAC inhibitor","5311","HDAC inhibitor","HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9","hematologic malignancy","cutaneous T-cell lymphoma (CTCL)","Launched"
"150","m-3M3FBS","HA1E","trt_cp","down",-0.210079391739026,0.162510391666666,0.314451408995329,-0.774387199936351,-43.5519857206604,2241,-0.0232316159980904,103,100,"PLCB2; PLCB3; PLCD1; PLCG1; PLCG2",NA,"761523","phospholipase activator","PLCB2, PLCB3, PLCD1, PLCG1, PLCG2","","","Preclinical"
"151","SB-222200","HA1E","trt_cp","down",-0.206422764106632,0.182443918074043,0.314451408995329,-0.760908268899757,-39.8036590807675,2241,0,103,100,"TACR3","Tachykinin antagonist","6604009","tachykinin antagonist","TACR3","","","Preclinical"
"152","entinostat","HA1E","trt_cp","down",-0.201965082916714,0.202205938190978,0.314451408995329,-0.74447652266185,-37.037037037037,2241,0,103,100,"HDAC1; HDAC2; HDAC3; HDAC9","HDAC inhibitor","4261","HDAC inhibitor","HDAC1, HDAC2, HDAC3, HDAC9","","","Phase 3"
"153","gabazine","HA1E","trt_cp","down",-0.201454602325342,0.207062555929394,0.314451408995329,-0.742594807218458,-29.8527443105756,2241,0,103,100,"GABRA2; GABRA3; GABRA4; GABRA5; GABRA6; GABRG2","GABA receptor antagonist","107895","GABA receptor antagonist","GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2","","","Preclinical"
"154","desipramine","HA1E","trt_cp","down",-0.199993305339518,0.211857943180458,0.314451408995329,-0.737208226118044,-36.590807675145,2241,0,103,100,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; ADRB1; ADRB2; CHRM1; CHRM4; CHRM5; HRH1; SLC22A3; SLC6A2; SLC6A4; SMPD1; TH","Tricyclic antidepressant","2995","tricyclic antidepressant","ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1","neurology/psychiatry","depression","Launched"
"155","papaverine","HA1E","trt_cp","down",-0.198075171984725,0.221300384977442,0.314451408995329,-0.73013767100349,-35.921463632307,2241,0,103,100,"PDE10A; PDE4B; PDE5A","Phosphodiesterase inhibitor","6084","phosphodiesterase inhibitor","PDE10A, PDE4B, PDE5A","cardiology, hematology, gastroenterology","myocardial infarction, angina pectoris, pulmonary embolism (PE), colitis, vascular spasm","Launched"
"156","maprotiline","HA1E","trt_cp","down",-0.195473888435715,0.234854473583397,0.314451408995329,-0.720548911882078,-32.4854975457385,2241,0,103,100,"ADRA1A; ADRA1B; ADRA1D; ADRA2B; ADRA2C; CHRM1; CHRM4; CHRM5; HRH1; HTR7; SLC6A2","Norepinephrine reuptake inhibitor; Tricyclic antidepressant","4011","norepinephrine reputake inhibitor, tricyclic antidepressant","SLC6A2","neurology/psychiatry","depression, dysthymic disorder","Launched"
"157","bezafibrate","HA1E","trt_cp","down",-0.194552464788421,0.234854473583397,0.314451408995329,-0.717152392726742,-36.7246764837126,2241,-0.265346385308894,103,100,"APOA1; APOA2; APOB; APOE; CETP; CRAT; HBE1; HBG1; HBG2; HSD11B1; LPL; NR1I2; PPARA; PPARD; PPARG; RXRA; RXRB; RXRG; SERPINE1; UCP3","PPAR receptor agonist","39042","PPAR receptor agonist","PPARA, PPARD, PPARG","cardiology","cholesterol","Launched"
"158","xylazine","HA1E","trt_cp","down",-0.192779695985401,0.243428264959072,0.314451408995329,-0.710617675265209,-46.2293618920125,2241,0,103,100,"ADRA2B; ADRA2C","Adrenergic receptor agonist","5707","adrenergic receptor agonist","ADRA2A, ADRA2B, ADRA2C","neurology/psychiatry","anesthetic","Launched"
"159","FIT","HA1E","trt_cp","down",-0.192516557713847,0.243428264959072,0.314451408995329,-0.709647704305097,-29.9866131191432,2241,0.0309951782076119,103,100,"OPRD1","Opioid receptor agonist","84008","opioid receptor agonist","OPRD1","","","Preclinical"
"160","finasteride","HA1E","trt_cp","down",-0.190578796578763,0.25156297673124,0.314451408995329,-0.702504797963255,-26.4167782240071,2241,-0.703059392028422,103,100,"AKR1D1; AR; KLK3; SRD5A1; SRD5A2","5-alpha reductase inhibitor","10970751","5 alpha reductase inhibitor","AKR1D1, SRD5A1, SRD5A2","endocrinology","androgenetic alopecia","Launched"
"161","nitrendipine","HA1E","trt_cp","down",-0.190107444823094,0.255458510817974,0.314451408995329,-0.700767317845683,-32.9317269076305,2241,0,103,100,"CACNA1C; CACNA1D; CACNA1H; CACNA1S; CACNA2D1; CACNA2D2; CACNB2; CACNG1; KCNN4","Calcium channel blocker","4507","calcium channel blocker","CACNA1D, CACNA2D1, KCNN4","cardiology","hypertension","Launched"
"162","nitrocaramiphen","HA1E","trt_cp","down",-0.188395620436031,0.262838438245703,0.314451408995329,-0.694457251527864,-22.4453369031682,2241,0,103,100,NA,"Cholinergic receptor antagonist","25102587","cholinergic receptor antagonist","CHRM1","","","Preclinical"
"163","xaliproden","HA1E","trt_cp","down",-0.187372500562778,0.266346135727406,0.314451408995329,-0.690685863352714,-31.4145470771977,2241,0,103,100,"MAPK3","Serotonin receptor agonist","128919","serotonin receptor agonist","HTR1A","","","Phase 3"
"164","SKF-81297","HA1E","trt_cp","down",-0.185194282944921,0.272951869573056,0.314451408995329,-0.682656594855783,-30.5667112896029,2241,-0.252582940096639,103,100,"DRD1","Dopamine receptor agonist","11957706","dopamine receptor agonist","DRD1, DRD5","","","Preclinical"
"165","resveratrol","HA1E","trt_cp","down",-0.181605415617589,0.281727760723615,0.314451408995329,-0.669427439451486,-30.8344489067381,2241,0,103,100,"AHR; AKT1; ALOX15; ALOX5; APOA1; APP; ATP5A1; ATP5B; ATP5C1; BACE1; CBR1; CLEC14A; CSNK2A1; ITGA5; ITGB3; KHSRP; MAOA; MAT2B; MTNR1A; MTNR1B; NQO2; NR1I2; NR1I3; PI4K2B; PPARA; PPARG; SCN5A; SIRT1; SIRT5; SLC2A1; SNCA; SULT1B1; TXNRD1; TXNRD2; YARS","Cytochrome P450 inhibitor; SIRT activator","445154","cytochrome P450 inhibitor, SIRT activator","CSNK2A1, NQO2, PTGS1, PTGS2","","","Launched"
"166","sonidegib","HA1E","trt_cp","down",-0.17556716741051,0.295424807503664,0.314451408995329,-0.64716946315551,-34.4489067380634,2241,0,103,100,"SMO",NA,"24775005","smoothened receptor antagonist","SMO","oncology","basal cell carcinoma (BCC)","Launched"
"167","RHC-80267","HA1E","trt_cp","down",-0.166410315286467,0.308245348778561,0.314451408995329,-0.613415799752973,-26.4167782240071,2241,0,103,100,"DAGLA; DAGLB; LIPC; LIPE; LIPG","Triacylglycerol lipase inhibitor","5063","triacylglycerol lipase inhibitor","DAGLA, DAGLB","","","Preclinical"
"168","emetine","HA1E","trt_cp","down",-0.161932869425326,0.31079988297013,0.314451408995329,-0.596911197685278,-33.1548415885765,2241,0,103,100,"MRPS7; RPS11; RPS12; RPS13; RPS14; RPS15; RPS15A; RPS16; RPS19; RPS2; RPS20; RPS21; RPS23; RPS24; RPS25; RPS27; RPS27L; RPS28; RPS29; RPS3; RPS3A; RPS5; RPS6; RPS7; RPS8; RPSA; RPSAP58; RSRC1","Protein synthesis inhibitor","10219","protein synthesis inhibitor","RPS2","","","Phase 2"
"169","mebendazole","NKDBA","trt_cp","down",-0.161042162194474,0.311275953273174,0.314451408995329,-0.650409972634007,NA,229,0,103,100,"TUBA1A; TUBB; TUBB4B","Tubulin inhibitor","4030","tubulin polymerization inhibitor","TUBA1A, TUBB, TUBB4B","infectious disease","pinworm, whipworm, hookworm, ascariasis","Launched"
"170","digoxigenin","HA1E","trt_cp","down",-0.155696310091458,0.312944843080883,0.314451408995329,-0.57392221395007,-29.9866131191432,2241,-0.579423584251252,103,100,"ATP1A1","Steroid","15478","steroid","","","","Preclinical"
"171","EMD-386088","HA1E","trt_cp","down",-0.148873326175558,0.31398558729198,0.314451408995329,-0.548771572727687,-21.954484605087,2241,-0.554057330033486,103,100,"HTR6","Serotonin receptor agonist","10131112","serotonin receptor agonist","HTR6","","","Preclinical"
